According to the requirements of the Clean Production Promotion Law of the People's Republic of China and the Clean Production Audit Measures, we hereby publicly disclose the basic information of our company's enterprises and the production and pollution discharge status before the audit.
Read MoreOn the morning of August 22nd, Chen Zhichang, Secretary of the Municipal Party Committee, led a team to conduct on-site research on the construction site of the new factory area project of Zhengda Qingjiang Pharmaceutical.
Read MoreOn the afternoon of July 8th, Huang Zhizhen, a second level inspector of the Jiangsu Provincial Intellectual Property Bureau, and his delegation visited the company to conduct intellectual property research, understand the current situation of enterprise intellectual property work,
Read MoreEach department and department: In order to strengthen safety awareness and improve safety quality, the company launched the "Five Ones" activity of Safety Production Month in June 2023.
Read MoreRecently, Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd. received a Drug Clinical Trial Approval Notice from the National Medical Products Administration, agreeing to conduct clinical trials on QJ-19-0002 tablets for gout patients with hyperuricemia.
Read More